An Open-Label, Definitive Bioequivalence Study to Compare the Pharmacokinetics of the Simvastatin, Nicotinic Acid, and MK0524 Components of a Formulation of MK0524B With That of Zocor and MK0524A Tablets.

Trial Profile

An Open-Label, Definitive Bioequivalence Study to Compare the Pharmacokinetics of the Simvastatin, Nicotinic Acid, and MK0524 Components of a Formulation of MK0524B With That of Zocor and MK0524A Tablets.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jun 2015

At a glance

  • Drugs Laropiprant/niacin/simvastatin (Primary) ; Niacin/laropiprant; Simvastatin
  • Indications Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia; Low HDL cholesterol
  • Focus Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 28 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top